axs-05
Showing 1 - 9 of 9
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation Trial in United States (AXS-05, Placebo)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- Placebo
-
Peoria, Arizona
- +22 more
Dec 12, 2022
MDD, Treatment Resistant Depression Trial in New York (AXS-05, Bupropion SR)
Enrolling by invitation
- Major Depressive Disorder
- Treatment Resistant Depression
- AXS-05
- Bupropion SR
-
New York, New YorkAxsome Research Site
Jul 20, 2021
MDD Trial in United States (AXS-05, Bupropion)
Treatment Resistant Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Treatment Resistant Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Little Rock, Arkansas
- +19 more
Jul 8, 2022
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Canada, United States
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- Placebo
-
Sun City, Arizona
- +62 more
Dec 13, 2022
Treatment Resistant MDD Trial in United States (AXS-05, Bupropion)
Completed
- Treatment Resistant Major Depressive Disorder
- AXS-05
- Bupropion
-
Phoenix, Arizona
- +73 more
Mar 22, 2021
Smoking Cessation, Smoking, Cigarette, Nicotine Dependence Trial in Durham (AXS-05, Bupropion SR)
Completed
- Smoking Cessation
- +2 more
- AXS-05
- Bupropion SR
-
Durham, North CarolinaDuke Center for Smoking Cessation
Mar 17, 2020
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Australia, United States
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- +2 more
-
Phoenix, Arizona
- +61 more
Oct 7, 2020